DOC2A Antikörper (Middle Region)
Kurzübersicht für DOC2A Antikörper (Middle Region) (ABIN951966)
Target
Alle DOC2A Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 284-314, Middle Region
-
Spezifität
- This antibody recognizes Human DOC2A (Center).
-
Aufreinigung
- Protein A column, followed by peptide affinity purification
-
Immunogen
- KLH conjugated synthetic peptide between 284-314 amino acids from the Central region of Human DOC2A
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- DOC2A (Double C2-Like Domains, alpha (DOC2A))
-
Andere Bezeichnung
- DOC2A
-
Hintergrund
- There are at least two protein isoforms of the Double C2 protein, namely alpha (DOC2A) and beta (DOC2B), which contain two C2-like domains. DOC2A and DOC2B are encoded by different genes, these genes are at times confused with the unrelated DAB2 gene which was initially named DOC-2. DOC2A is mainly expressed in brain and is suggested to be involved in Ca(2+)-dependent neurotransmitter release.Synonyms: Doc2, Doc2-alpha, Double C2-like domain-containing protein alpha
-
Molekulargewicht
- 43959 Da
-
Gen-ID
- 8448
-
NCBI Accession
- NP_003577
-
Pathways
- Synaptic Vesicle Exocytosis
Target
-